Elaine Mardis and her colleagues at Washington University in St. Louis sequenced the genome of a man with acute myeloid leukemia using Illumina's Genome Analyzer II and identified 64 mutations, according the report in the New England Journal of Medicine. Of those, 12 were somatic mutations in coding regions and 52 were somatic point mutations in conserved or regulatory regions. Four of the mutations also occurred in at least one other AML sample that had also been tested and two of these were already known mutations. In a statement, senior author Timothy Ley says, "Only by sequencing complete genomes of cancer patients are we going to find unexpected, recurring genetic mutations that are highly likely to be important for cancer to develop and grow."
Searching for Recurrent Mutations
Aug 06, 2009